Abstract: The present inventors provide miRNAs useful in the diagnosis and prediction, with high accuracy, of the risk of a subject to suffering from a thrombosis condition. The present invention also provides a method for deciding or recommending initiating a medical anti-thrombotic therapy.

Abstract: The present invention is directed to in vitro methods for determining the fitness of a subject based on the determination of the expression levels of different genes. The invention also provides an in vitro method for selecting a subject as having a fitness level suitable to participate in an endurance sport, for monitoring the response to training of a subject during an endurance exercise training and for selecting a personalized training program aimed at improving fitness of a subject, based on the determination of the expression levels of said genes, as well as a kit comprising reagents for determining said expression levels and the use thereof, a computer program and a computer-implemented method.